Additionally, key pro-inflammatory cytokines, such as interleukin (IL)-6 and TNF-α, play pivotal roles in RA pathophysiology and are increasingly leveraged as both biomarkers and therapeutic targets. Here, IL6 is linked to rheumatoid arthritis.